IOL Chemicals and Pharmaceuticals Limited (IOLCP.BO)
IOL Chemicals and Pharmaceuticals Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Ludhiana, PU, IN. The stock last traded at $165.35, down 0.42% on the session, giving a market capitalisation of $48.55B. Its beta of 0.48 implies it has historically moved less than the broad market.
IOL Chemicals and Pharmaceuticals Limited is a global manufacturer and supplier of a diverse range of pharmaceutical and chemical products. The company’s pharmaceutical portfolio focuses on Active Pharmaceutical Ingredients (APIs), providing essential compounds such as ibuprofen lysinate and ibuprofen sodium, alongside a variety of other APIs like metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole, gabapentin, levetiracetam, and paracetamol. These APIs are utilized in medications designed for treatments spanning anti-inflammatory, analgesic, antipyretic, anti-diabetic, anti-platelet, anti-cholesterol, anti-convulsant, and anti-cholelithic purposes, as well as proton pump inhibition. Additionally, IOL offers specialty industrial chemicals, including ethyl acetate, iso butyl benzene, acetyl chloride, para amino phenol, and mono chloro acetic acid. These chemicals cater to a broad spectrum of industries, including food processing, flexible packaging, textiles, ink and paint production, pesticide manufacturing, and other chemical intermediate applications. Incorporated in 1986, IOL Chemicals and Pharmaceuticals Limited is based in Ludhiana, India.
IOL Chemicals and Pharmaceuticals Limited is most often compared with the following Healthcare names: